ArticleClinical epigenetics2021

DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status.

Philipp Jurmeister et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.